Birte K. Skrumsager - Concepedia

Author

Birte K. Skrumsager

Also Known As

B SKRUMSAGER, B Skrumsager, B. K. SKRUMSAGER, B. K. Skrumsager, B. Skrumsager, B.K. Skrumsager, Birte K. Skrumsager, Birte Skrumsager

Publications

832

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)Peter MacCallum Cancer Centre Cancer Trials Australia Austin Health

About

Birte K. Skrumsager is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	204
2	Neuroscience	2	2	143
3	Social Sciences	1	1	13
4	Diabetes	1	1	48
5	Neurology	1	1	13

Birte K. Skrumsager

Publications

740

Citations

H-Index

Page 1

	Year	Citations
An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma Ian D. Davis, Birte K. Skrumsager, Jonathan Cebon, Clinical Cancer Research	2007	164
Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial Ian D. Davis, Ben Brady, Richard Kefford, Clinical Cancer Research	2009	138
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor Per Karlsson, Lars Farde, Christer Halldin, Psychopharmacology Functional SelectivityMedicineNeurotransmitterPet ExaminationD1-dopamine Receptor	1993	130
IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A. Freeman, Cancer Immunology Immunotherapy	2008	114
A Tolerance Study of Single and Multiple Dosing of the Selective Dopamine Uptake Inhibitor GBR 12909 in Healthy Subjects Ulf Søgaard, Bridget Butler, Alex Lund Laursen, International Clinical Psychopharmacology	1990	59
Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes Birte K. Skrumsager, Karin Kramer Nielsen, M. Müller, The Journal of Clinical Pharmacology Peripheral EdemaNovel Dual PparαHealthy SubjectsMedicineInsulin Management	2003	48
Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial Stanislav Ignatenko, Birte K. Skrumsager, Ulrik Mouritzen International Journal of Clinical Pharmacology and Therapeutics	2016	43
Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator Birte K. Skrumsager, Bénédicte Kiehr, Poul Christian Pedersen, British Journal of Clinical Pharmacology	2002	18
Inhibition of photosensitive seizures in man by the β-carboline, ZK 95962, a selective benzodiazepine receptor agonist Arne Møller, Leif H. Jensen, Birte K. Skrumsager, Epilepsy Research Molecular PharmacologyMedicinePsychopharmacologyNeuropharmacologyPhotosensitive Seizures	1990	13
"Treatment of obesity by femoxetine a selective 5 HT reuptake inhibitor'. J. Smedegaard, Philip A. Christiansen, Birte K. Skrumsager PubMed ObesityMolecular PharmacologyMetabolic DisorderMedicinePhysiology	1981	13

Page 1